Deferoxamine Mesylate

Spezifikationen

138-14-7CAS-Nummer

205-314-3EG-Nummer

N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide;methanesulfonic acidIUPAC-Name

C26H52N6O11SChemische Formel

656.8 g/molMolekulargewicht

Deferoxamine mesylate; 138-14-7; Desferal; Desferrioxamine B mesylate; Desferrioxamine mesylate; Deferoxamine mesilate; Desferal mesylate; Deferoxamine B mesylate; Deferoxamine methanesulfonate; DESFERRIOXAMINE MESILATE; Desferrioxamine methanesulfonate; DTXSID6037649; V9TKO7EO6K; Deferoxamini mesilas; NSC-756718; Desferrioxamine B methanesulfonate; Ba-33112; DTXCID4017649; NSC644468; CHEBI:31460; Mesilate, Deferoxamine; Mesylate, Deferoxamine; RefChem:585617; Mesylate, Desferrioxamine B; Methanesulfonate, Deferoxamine; 205-314-3; N-(5-(Acetylhydroxyamino)pentyl)-N'-(5-(3-((5-aminopentyl)hydroxycarbamoyl)propanoylamino)pentyl)-N'-hydroxysuccinamide monomethanesulfonate; Deferoxamine mesylate salt; Deferoxamine (mesylate); MFCD00058605; MLS000028713; Desferrioxamine B mesylate;DFOM; N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide;methanesulfonic acid; NCGC00017021-01; CAS-138-14-7; Desferal (TN); N-(5-(3-((5-Aminopentyl)hydroxycarbamoyl)propionamido)pentyl)-3-((5-(N-hydroxyacetamido)pentyl)carbamoyl)propionohydroxamic acid monomethanesulfonate (salt); N1-(5-aminopentyl)-N1-hydroxy-N4-(5-(N-hydroxy-4-((5-(N-hydroxyacetamido)pentyl)amino)-4-oxobutanamido)pentyl)succinamide methanesulfonate; Desferal methanesulfonate; Deferoxamine mesylate [USAN]; C26H52N6O11S; SR-01000695424; SMR000058548; EINECS 205-314-3; UNII-V9TKO7EO6K; Ba 33122; CCRIS 8311; Deferoxamine mesylate [USAN:USP]; N-[5-[3-[(5-Aminopentyl)hydroxycarbamoyl]propionamido]pentyl]-3-[[5-(N-hydroxyacetamido)pentyl]carbamoyl]propionohydroxamic acid monomethanesulfonate (salt); Prestwick_988; Deferoxamine mesilate CRS; CHEMBL1234; Deferoxamine mesylate (USP); SCHEMBL119982; SPECTRUM1500224; Deferoxamine mesilate (JP17); orb1307936; HMS500E04; HY-B0988R; GLXC-07726; HMS1570A12; HMS1920C16; HMS2091K08; HMS2097A12; HMS2234H23; HMS3714A12; HMS5085M21; Pharmakon1600-01500224; DEFEROXAMINE MESILATE [JAN]; Deferoxamine (mesylate) (Standard); EX-A4085; HY-B0988; Tox21_110741; CCG-39770; DEFEROXAMINE MESYLATE [VANDF]; NSC756718; s5742; AKOS026750165; DEFEROXAMINE MESILATE [WHO-DD]; DEFEROXAMINE MESILATE [WHO-IP]; DEFEROXAMINE MESYLATE [USP-RS]; Tox21_110741_1; CS-4479; EBC-102073; FD20885; NSC 756718; NSC-644468; DESFERRIOXAMINE MESILATE [MART.]; DESFERRIOXAMINE MESYLATE [WHO-IP]; NCGC00017021-02; NCGC00017021-03; NCGC00094640-01; NCGC00094640-02; NCGC00178802-06; AC-36517; Butanediamide, N'-(5-((4-((5-(acetylhydroxyamino)pentyl)amino)-1,4-dioxobutyl)hydroxyamino)pentyl)-N-(5-aminopentyl)-N-hydroxy-, monomethanesulfonate; DEFEROXAMINE METHANESULFONATE [MI]; Propionohydroxamic acid, N-(5-(3-((5-aminopentyl)hydroxycarbamoyl)propionamido)pentyl)-3-((5-(N-hydroxyacetamido)pentyl)carbamoyl)-, monomethanesulfonate (salt); SY066727; DEFEROXAMINE MESYLATE [ORANGE BOOK]; DB-042415; DEFEROXAMINE MESILATE [EP MONOGRAPH]; DEFEROXAMINI MESILAS [WHO-IP LATIN]; DEFEROXAMINE MESYLATE [USP MONOGRAPH]; NS00079182; D-0675; D01186; SR-01000695424-2; SR-01000695424-3; SR-01000695424-4; Deferoxamine mesylate salt, powder, >=92.5% (TLC); Q27114315; Deferoxamine mesylate salt, European Pharmacopoeia (EP) Reference Standard; Deferoxamine mesylate, United States Pharmacopeia (USP) Reference Standard; Deferoxamine for system suitability, European Pharmacopoeia (EP) Reference Standard; (Z)-4-((5-aminopentyl)(hydroxy)amino)-N-(5-((Z)-N,4-dihydroxy-4-((5-(N-hydroxyacetamido)pentyl)imino)butanamido)pentyl)-4-oxobutanimidic acid compound with methanesulfonic acid (1:1); BUTANEDIAMIDE, N'(-(((((ACETYLHYDROXYAMINO)PENTYL)MINO)1,4-DIOXOBUTYL)YDROXYAMINO)ENTYL)N-(5-AMINOPENTYL)-N-HYDROXY-, MONOMETHANESULFONATE; BUTANEDIAMIDE, N'(-(((((ACETYLHYDROXYAMINO)PENTYL)MINO)1,4-DIOXOBUTYL)YDROXYAMINO)ENTYL)N-(5-AMINOPENTYL)-N-HYDROXY-, MONOMETHANESULPHONATE; Methanesulfonic acid--N~1~-(5-aminopentyl)-N~1~-hydroxy-N~4~-[5-(N-hydroxy-4-{[5-(N-hydroxyacetamido)pentyl]amino}-4-oxobutanamido)pentyl]butanediamide (1/1); N-(5-(3-((5-AMINOPENTYL)HYDROXYCARBAMOYL)PROPIONAMIDO)PENTYL)-3-((5-(N-HYDROXYACETAMIDO)PENTYL)CARBAMOYL)PROPIONOHYDROXAMIC ACID MONOMETHANESULPHONATE (SALT); N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxo-butanoyl]-hydroxy-amino]pentyl]-N'-(5-aminopentyl)-N'-hydroxy-butanediamide;methanesulfonic acidSynonyme